APA (7th ed.) Citation

Mengel, D., Soter, E., Ott, J. M., Wacker, M., Leyva, A., Peters, O., . . . Synofzik, M. (2025). Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease. Molecular Psychiatry, 1. https://doi.org/10.1038/s41380-025-03021-0

Chicago Style (17th ed.) Citation

Mengel, David, et al. "Blood Biomarkers Confirm Subjective Cognitive Decline (SCD) as a Distinct Molecular and Clinical Stage Within the NIA-AA Framework of Alzheimer´s Disease." Molecular Psychiatry 2025: 1. https://doi.org/10.1038/s41380-025-03021-0.

MLA (9th ed.) Citation

Mengel, David, et al. "Blood Biomarkers Confirm Subjective Cognitive Decline (SCD) as a Distinct Molecular and Clinical Stage Within the NIA-AA Framework of Alzheimer´s Disease." Molecular Psychiatry, 2025, p. 1, https://doi.org/10.1038/s41380-025-03021-0.